Patient trust, physician credibility, and payer goodwill are not soft considerations alongside the balance sheet; they are the mechanism by which a pharmaceutical product generates revenue over time.
The post Ethics Isn’t a Pharma Value — It’s a Competitive Moat appeared first on MedCity News.
